secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2025-01-23T23:59:59+00:00
Accession:  0001493152-25-003425
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs sells Pharmaloz subsidiaries for $2M cash and $10M debt relief
----------------------------------------------------------------------------

- JL Projects purchased all shares of Pharmaloz Manufacturing and Pharmaloz Real Estate; transaction closed Jan 16, 2025.
- JL Projects provided $2M cash and extinguished $10M of ProPhase's debt; also cancelled $300K accrued interest.
- JL Projects assumed $3.3M mortgage, $2M capital leases, and $3M payables; paid down $200K affiliate loan.
- ProPhase avoided $3M in upcoming capex and transferred $600K employee overhead to PMI.
- Sale includes customary representations and warranties; full agreement filed as Exhibit 2.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000149315225003425/0001493152-25-003425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000149315225003425/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer